Dr E V Kalyani Medical Foundation Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 07-07-2024
- Paid Up Capital ₹ 0.25 M
as on 07-07-2024
- Company Age 40 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.08 M
as on 07-07-2024
- Satisfied Charges ₹ 8.91 M
as on 07-07-2024
- Revenue %
(FY 2020)
- Profit 76.37%
(FY 2020)
- Ebitda 94.43%
(FY 2020)
- Net Worth -5.36%
(FY 2020)
- Total Assets -5.36%
(FY 2020)
About Dr E V Kalyani Medical Foundation
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.25 M.
The company currently has active open charges totaling ₹2.08 M. The company has closed loans amounting to ₹8.91 M, as per Ministry of Corporate Affairs (MCA) records.
Gita Arjun and Arjun Rajagopalan serve as directors at the Company.
- CIN/LLPIN
U85110TN1984PTC010669
- Company No.
010669
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Feb 1984
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dr E V Kalyani Medical Foundation?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gita Arjun  | Director | 09-Jul-1990 | Current |
| Arjun Rajagopalan | Director | 22-Feb-1984 | Current |
Financial Performance of Dr E V Kalyani Medical Foundation.
Dr E V Kalyani Medical Foundation Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 76.37% increase in profit. The company's net worth dipped by a decrease of 5.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr E V Kalyani Medical Foundation?
In 2018, Dr E V Kalyani Medical Foundation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Maksym Global Solutions Private LimitedActive 24 years 10 monthsArjun Rajagopalan is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Investment Trust Of India Ltd. Creation Date: 30 Mar 1992 | ₹0.39 M | Open |
The Investment Trust Of India Ltd Creation Date: 20 Feb 1991 | ₹0.76 M | Open |
The Investment Trust Of India Ltd Creation Date: 05 Apr 1988 | ₹0.60 M | Open |
How Many Employees Work at Dr E V Kalyani Medical Foundation?
Unlock and access historical data on people associated with Dr E V Kalyani Medical Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr E V Kalyani Medical Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr E V Kalyani Medical Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
